Status:
RECRUITING
A Pragmatic INitiative for LDL-C Management by a CLinical Pharmacist-Led Team Among Atherosclerotic CardiovascUlar DisEase Patients
Lead Sponsor:
Intermountain Health Care, Inc.
Conditions:
Atherosclerotic Cardiovascular Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients who had an ASCVD event at an Intermountain hospital will be screened for eligibility to be randomized. Subjects who meet eligibility criteria will be randomized 1:1 to receive targeted care o...
Eligibility Criteria
Inclusion
- Male or female \>18 years of age
- Receive follow-up care with Intermountain Health
- Value-based patient (as defined in the EDW)
- Documentation of an ASCVD diagnosis, by 1 of the following:
- Coronary artery disease (Primary inpatient CAD diagnosis during index encounter; Primary inpatient MI diagnosis during index encounter; PCI during index encounter; or CABG during index encounter
- Cerebrovascular accident (Primary inpatient ischemic stroke diagnosis during index encounter; Carotid endarterectomy during index encounter; or Carotid stent during index encounter)
- Peripheral arterial disease (Bypass or percutaneous intervention during index encounter)
Exclusion
- Patient age \<18 years.
- Receipt of or expected receipt of palliative care, expected discharge to hospice, or long-term care facility (i.e., skilled nursing facility).
- Pregnant or lactating women
Key Trial Info
Start Date :
January 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06571162
Start Date
January 30 2025
End Date
September 1 2028
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intermountain Healthcare Hospitals and Clinics
Salt Lake City, Utah, United States, 84107